Rhenman & Partners Asset Management AB

Rhenman Healthcare Equity L/S IC1 (EUR)

Strategy Description

Rhenman Healthcare Equity L/S is a global long-biased equity fund with an exclusive focus on healthcare. Because the United States is a dominant player within healthcare, the fund’s equity allocation is usually two-thirds in the United States and one-third in the rest of the world. The spread is normally roughly a quarter in each sub-sector (pharmaceuticals, biotechnology, medical technology, and service). The hedge fund’s free investment rules offer far greater opportunities compared to conventional mutual funds. The fund diversifies across company sizes, various sub-sectors and geographies to lower volatility, and has an absolute return target.

General Information

NHX CategoryEquities
NHX CountrySweden
Legal StructureUCITS
Fund DomicileLuxembourg
Minimum Investment250,000 EUR
AUM509M EUR
Highwater MarkYes
Inception DateJun 2009
Management Fee1.5%
Performance Fee20%

Company Information

CompanyRhenman & Partners Asset Management AB
PrincipalCarl Grevelius
AddressStrandvägen 5A
Stockholm, 114 51
Phone+4684598880
Emailinfo@rhepa.com

Monthly Performance

  JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC Year
2017 5.21 11.28 4.33 0.29 -8.98 9.79 -1.52 4.32 1.06 -1.06 5.02 32.06
2016 -18.50 -5.40 -0.22 5.03 7.05 -2.91 9.45 -2.61 1.74 -11.67 8.47 0.84 -12.01
2015 11.02 7.15 6.99 -6.16 10.08 -1.54 4.45 -10.95 -12.64 8.35 7.09 -1.60 20.09
2014 6.94 5.01 -5.34 -5.54 5.32 5.32 0.50 7.45 2.43 7.28 3.83 4.08 42.82
2013 6.29 5.44 7.75 3.39 5.39 -3.14 11.52 -0.98 4.38 -3.34 9.31 0.05 55.29
2012 5.82 1.10 3.83 0.52 -0.15 6.00 1.05 0.00 2.94 -5.16 2.81 -1.50 18.08
2011 -0.98 2.26 -0.75 3.60 5.05 -3.71 -0.83 -6.89 -0.90 6.25 1.44 5.58 9.66
2010 4.09 1.72 6.33 -4.09 -11.10 -2.14 -3.35 -0.20 7.13 2.01 3.58 5.65 8.34
2009 0.75 4.41 2.17 0.33 -6.34 4.66 7.17 13.28
There is a substantial risk of loss in trading commodity futures, equities, options and off-exchange foreign currency products. Past performance is not indicative of future results.

Return Statistics

Last Month 5.02
3 Month ROR 5.01
Year To Date 32.06
12 Month ROR 33.17
36 Month ROR 45.25
Compound ROR 20.61
Winning Months (%) 66.67
Average Winning Month 4.84
Average Losing Month -4.35
Total Return 391.88

Risk Statistics

Sharpe Ratio 1.07
Sortino Ratio 1.53
Sterling Ratio 0.46
Calmar Ratio 0.42
Skewness -0.89
Kurtosis 1.13
Maximum Drawdown -31.67
Correlation vs S&P 500 0.50
Average Losing Month -4.35
Standard Deviation (monthly) 5.60
Downside Deviation 3.57

Risk/Return Chart

Monthly Returns

Performance (VAMI)

Distribution of Monthly Returns

12 Month Rolling ROR

Drawdown Report

No. Depth (%) Length (Months) Recovery (Months) Start date End date
1 -31.67 8 20 08/2015 11/2017
2 -19.52 5 8 04/2010 04/2011
3 -11.89 4 3 06/2011 12/2011
4 -10.58 2 4 03/2014 08/2014
5 -6.34 1 2 10/2009 12/2009

Return Report

Period BestWorstAverageMedianLastWinning %
1 Month 11.52-18.501.732.355.0265.69
3 Months 27.27-24.135.276.885.0174.00
6 Months 47.55-27.6110.7812.1918.4478.35
1 Year 77.55-27.4122.3123.1633.1784.62
2 Years 135.41-10.3851.6640.8414.3496.20
3 Years 208.7940.2999.0084.1345.25100.00
5 Years 363.40160.99212.75202.84204.87100.00

Up Capture vs. NHX Composite

Down Capture vs. NHX Composite

Drawdown

Volatility (12 Months Rolling)

Time Window Analysis

1 Month3 Months6 Months1 Year2 Years3 Years
Average ROR5.021.642.862.420.561.04
% Positive100.0066.6766.6775.0058.3361.11
Avg. Pos. Period5.023.045.054.685.286.05
Avg. Neg. Period - -1.06-1.29-3.85-5.45-6.13
Sharpe0.001.882.361.630.400.62
Sortino0.009.3013.103.160.380.71
Std. Deviation0.003.094.305.407.067.37
Down. Deviation0.000.610.762.655.045.08

AUM

ALL DATA INCLUDING PERFORMANCE NUMBERS HAVE BEEN SUPPLIED BY THE RESPECITVE MANAGERS AND FUND. HEDGENORDIC IN NO WAY GUARANTEES THE ACCURACY OF THESE NUMBERS AND HAS SUPPLIED THEM TO YOU FOR INFORMATION PURPOSES ONLY. THIS DOES NOT CONSTITUTE A SOLICITATION TO BUY OR AN OFFER TO SELL. NO INVESTMENT SHOULD BE MADE WITHOUT FULLY REVIEWING THE ASSOCIATED RISK FACTORS, FEES AND CONFLICTS OF INTEREST AS OUTLINED IN EACH FUNDS S RISK DISCLOSURE DOCUMENT. THERE MAY BE FUNDS WHO HAVE CHOSEN NOT TO BE LISTED IN THE HEDGENORDIC DATABASE AND NHX THAT MAY HAVE BETTER OR WORSE PERFORMANCE THAN THOSE IN OUR DATABASE.

THE RISK OF LOSS IN INVESTING IN HEDGEFUNDS CAN BE SUBSTANTIAL. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER SUCH TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CONDITION. PAST RESULTS ARE NOT NECESSARILY INDICATIVE OF FUTURE RESULTS. TRADE ONLY WITH RISK CAPITAL. SALES RESTRICTIONS MAY APPLY IN YOUR JURISDICTION.